Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3i Group is a leading international investment manager focused on mid-market private equity and infrastructure, with a significant historical and ongoing presence in the healthcare and life sciences sectors. Through its dedicated venture capital vehicles, such as 3i Technology Partners, the firm has provided growth capital to numerous companies in the medical device, diagnostic, and biotechnology industries. 3i's healthcare investment strategy emphasizes businesses with strong market positions, innovative technologies, and the potential for international expansion. Notable healthcare investments managed by 3i have included TransMedics, a pioneer in organ transplant technology, and various other medical technology innovators. The firm leverages its global network and operational expertise to support portfolio companies through clinical development and commercial scaling.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 3i Technology Partners.